Searched for
DRUGS CUSTOMS DUTY
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsGiven the state of the market these days, it would be wise to be selective. Not only in terms of stocks, but also in terms of sectors. For ...- TotalEnergies awaits ruling in high-stakes climate trialA French court will rule Thursday on whether oil and gas giant TotalEnergies breached its legal duty to address environmental risks in a hi...
- Death rate in ICE immigrant detention centers more than doubles under Trump, Reuters analysis findsFifty individuals have died in U.S. immigration detention since January 2025, a rate that has more than doubled since 2009. Concerns are ri...
- Call to extend duty cuts on critical inputs soonIndia is set to decide on extending customs duty relief for critical raw material imports beyond June 30. An inter-ministerial panel will r...
- Japanese investors are looking beyond China... India is key alternative: Tsutomu Takemura, Senior MD, NomuraIndia is increasingly becoming a long-term structural investment destination rather than a short-term strategic bet. Global capital is movi...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
- US raises concerns at India’s duties on IP-intensive goods, source code, AI working paperThe US has voiced concerns over India's high customs duties on IP-intensive products and its proposed mandatory blanket license for AI deve...
- Trump's $166 billion tariff refunds may finally be in sight as first payouts expected by May 11The Trump administration is set to issue its first tariff refunds around May 11, following the Supreme Court's ruling that the sweeping dut...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat we are witnessing in the market these days is similar to scenarios that have played out in the past. There have been many points in th...
- Companies told to revise MRP of duty-waived medicinesIn an office memorandum dated February 17, the nodal agency for price regulation has also directed these companies to issue a revised price...
- NPPA asks companies to cut prices of three cancer drugs post tax reliefIn a move aimed at providing relief to cancer patients, the National Pharmaceutical Pricing Authority (NPPA) has directed drug manufacturer...
- Budget 2024: Government proposes to fully exempt 3 cancer drugs from customs dutyThe government proposes to cut custom duties on Trastuzumab Deruxtecan, Osimertinib and Durvalumab from 10 per cent to nil. Finance Ministe...
- Delhi HC: No customs duties on rare disease medicinesDelhi High Court clarifies no custom duties on medicines for rare diseases, ensuring expedited clearance and access to necessary treatments...
- IGST a bitter pill for patients with rare disorders as medicines attract 5%-12%While life-saving medicines imported for personal use would continue to be exempt from basic customs duty, they are not exempt from IGST.
- Taking steps to discourage import of bulk drugs: GovernmentThe government is clearing bottlenecks like environment clearance which the manufacturers are facing in order to give boost to domestic man...
- Government reviewing move to withdraw customs duty exemption for drugsA notification issued last week by Central Board of Excise and Customs had announced that customs duty exemption on the import of 74 drugs ...
- Mamata Banerjee slammed centre for increasing custom duty on life saving drugsExpressing concern over the rising price of medicines, Bengal CM Mamata Banerjee today blamed the centre for ‘increasing the custom duty on...
- Budget 2013: OPPI looking for rationalisation of customs duty to 5% for formulationsAt present, BCD on formulations is 10% (other than specified drugs, life saving drugs, vaccines and bulk drugs for which the BCD rate is 5%...
- Budget 2013: Reduce customs and excise duty on nutraceuticals, supplements, says OPPIAccording to OPPI, basic customs duty(BCD) for health supplements should be slashed to 10% and additional customs duty(ACD)/central excise ...
Load More
